GALLUZZO, MARCO
GALLUZZO, MARCO
Dipartimento di Medicina dei sistemi
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab
2018-01-01 Galluzzo, M; D'Adamio, S; Campione, E; Mazzilli, S; Bianchi, L; Talamonti, M
A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab
2020-01-01 D'Adamio, S; Massaro, A; Biocca, S; Bianchi, L; Talamonti, M; Galluzzo, M
A safety evaluation of guselkumab for the treatment of psoriasis
2018-01-01 Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients.
2017-04-01 Talamonti, M; Galluzzo, M; Servoli, S; D'Adamio, S; Bianchi, L
Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis
2016-01-01 Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis
2017-01-01 Galluzzo, M; Talamonti, M; Perino, F; Servoli, S; Giordano, D; Chimenti, S; De Simone, C; Peris, K
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature
2019-04-10 Galluzzo, M; D'Adamio, S; Teoli, M; Bianchi, L; Talamonti, M
Brodalumab for the treatment of psoriasis
2016-01-01 Galluzzo, M; D'Adamio, S; Bianchi, L; Talamonti, M
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic: risk analysis from the PSO-BIO-COVID observational study
2021-01-01 Talamonti, M; Galluzzo, M; Chiricozzi, A; Quaglino, P; Fabbrocini, G; Gisondi, P; Marzano, Av; Potenza, C; Conti, A; Parodi, A; Piaserico, S; Bardazzi, F; Argenziano, G; Rongioletti, F; Stingeni, L; Micali, G; Loconsole, F; Rossi, Mt; Bongiorno, Mr; Feliciani, C; Rubegni, P; Amerio, P; Fargnoli, Mc; Pigatto, P; Savoia, P; Nisticò, Sp; Giustini, S; Carugno, A; Cannavo', Sp; Rech, G; Prignano, F; Offidani, A; Lombardo, M; Zalaudek, I; Bianchi, L; Peris, K
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
2020-01-01 Caldarola, G; Pirro, F; Di Stefani, A; Talamonti, M; Galluzzo, M; D'Adamio, S; Magnano, M; Bernardini, N; Malagoli, P; Bardazzi, F; Potenza, C; Bianchi, L; Peris, K; De Simone, C
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012-09-01 Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A
Diagnosis and management of cutaneous and anogenital lichen sclerosus: Recommendations from the Italian Society of Dermatology (SIDemaSt)
2021-01-01 Papini, M; Russo, A; Simonetti, O; Borghi, A; Corazza, M; Piaserico, S; Feliciani, C; Calzavara-Pinton, P; Amendolagine, G; Arisi, M; Babino, G; Bardazzi, F; Belloni Fortina, A; Cac-Cavale, S; Campanati, A; Campione, E; Caposiena, Cd; Carugno, A; Coati, I; Cinotti, E; D'Antuono, A; Dattola, A; Dika, E; Fai, D; Fusano, M; Galluzzo, M; Ganzetti, G; Gisondi, P; Hansel, K; Lora, V; Maione, V; Mandel, Vd; Menni, S; Negosanti, M; Neri, I; Offidani, A; Parodi, A; Patrizi, A; Peserico, A; Rossi, M; Rivetti, N; Saccani, E; Stan, Tr; Stingeni, L; Talamonti, M; Vascellaro, A; Vezzoli, P; Virgili, A; Zanca, A
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients
2018-01-01 Galluzzo, M; D’Adamio, S; Pastorino, R; Angela Andreoli, A; Servoli, S; Bianchi, L; Talamonti, M
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
2021-01-01 Patruno, C; Fabbrocini, G; Longo, G; Argenziano, G; Ferrucci, Sm; Stingeni, L; Peris, K; Ortoncelli, M; Offidani, A; Amoruso, Gf; Talamonti, M; Girolomoni, G; Grieco, T; Iannone, M; Nettis, E; Foti, C; Rongioletti, F; Corazza, M; Veneri, Md; Napolitano, M; Angileri, L; Bianchelli, T; Borghi, A; Calabrese, G; Chello, C; Dal Bello, G; Dastoli, S; Ferrillo, M; Galluzzo, M; Gori, N; Hansel, K; Macchia, L; Piras, V; Provenzano, E; Ribero, S; Romanelli, M; Romita, P
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
2018-01-01 Chimenti, Ms; Ortolan, A; Lorenzin, M; Triggianese, P; Talamonti, M; Costa, L; Caso, F; Favero, M; Teoli, M; Galluzzo, M; Scarpa, R; Punzi, L; Perricone, R; Ramonda, R
Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis
2011-01-01 Talamonti, M; Galluzzo, M; Teoli, M; Bavetta, M; Chimenti, S; Costanzo, A
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial
2019-01-01 Puviani, M; Galluzzo, M; Talamonti, M; Mazzilli, S; Campione, E; Bianchi, L; Milani, M; Luppino, I; Micali, G
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
2022-05-07 Galluzzo, M; Talamonti, M; Cioni, A; Maffei, V; Shumak, Rg; Tofani, L; Bianchi, L; Campione, E
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study
2019-01-01 Chimenti, Ms; Fonti, Gl; Conigliaro, P; Hitaj, J; Triggianese, P; Teoli, M; Galluzzo, M; Talamonti, M; Kroegler, B; Greco, E; Perricone, R
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom
2013-05-01 Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2018 | A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab | Galluzzo, M; D'Adamio, S; Campione, E; Mazzilli, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2020 | A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab | D'Adamio, S; Massaro, A; Biocca, S; Bianchi, L; Talamonti, M; Galluzzo, M | Articolo su rivista | |
| 1-gen-2018 | A safety evaluation of guselkumab for the treatment of psoriasis | Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-apr-2017 | Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. | Talamonti, M; Galluzzo, M; Servoli, S; D'Adamio, S; Bianchi, L | Articolo su rivista | |
| 1-gen-2016 | Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis | Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A | Intervento a convegno | |
| 1-gen-2017 | Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis | Galluzzo, M; Talamonti, M; Perino, F; Servoli, S; Giordano, D; Chimenti, S; De Simone, C; Peris, K | Articolo su rivista | |
| 10-apr-2019 | Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature | Galluzzo, M; D'Adamio, S; Teoli, M; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2016 | Brodalumab for the treatment of psoriasis | Galluzzo, M; D'Adamio, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2021 | Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic: risk analysis from the PSO-BIO-COVID observational study | Talamonti, M; Galluzzo, M; Chiricozzi, A; Quaglino, P; Fabbrocini, G; Gisondi, P; Marzano, Av; Potenza, C; Conti, A; Parodi, A; Piaserico, S; Bardazzi, F; Argenziano, G; Rongioletti, F; Stingeni, L; Micali, G; Loconsole, F; Rossi, Mt; Bongiorno, Mr; Feliciani, C; Rubegni, P; Amerio, P; Fargnoli, Mc; Pigatto, P; Savoia, P; Nisticò, Sp; Giustini, S; Carugno, A; Cannavo', Sp; Rech, G; Prignano, F; Offidani, A; Lombardo, M; Zalaudek, I; Bianchi, L; Peris, K | Articolo su rivista | |
| 1-gen-2020 | Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature | Caldarola, G; Pirro, F; Di Stefani, A; Talamonti, M; Galluzzo, M; D'Adamio, S; Magnano, M; Bernardini, N; Malagoli, P; Bardazzi, F; Potenza, C; Bianchi, L; Peris, K; De Simone, C | Articolo su rivista | |
| 1-set-2012 | Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis | Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A | Intervento a convegno | |
| 1-gen-2021 | Diagnosis and management of cutaneous and anogenital lichen sclerosus: Recommendations from the Italian Society of Dermatology (SIDemaSt) | Papini, M; Russo, A; Simonetti, O; Borghi, A; Corazza, M; Piaserico, S; Feliciani, C; Calzavara-Pinton, P; Amendolagine, G; Arisi, M; Babino, G; Bardazzi, F; Belloni Fortina, A; Cac-Cavale, S; Campanati, A; Campione, E; Caposiena, Cd; Carugno, A; Coati, I; Cinotti, E; D'Antuono, A; Dattola, A; Dika, E; Fai, D; Fusano, M; Galluzzo, M; Ganzetti, G; Gisondi, P; Hansel, K; Lora, V; Maione, V; Mandel, Vd; Menni, S; Negosanti, M; Neri, I; Offidani, A; Parodi, A; Patrizi, A; Peserico, A; Rossi, M; Rivetti, N; Saccani, E; Stan, Tr; Stingeni, L; Talamonti, M; Vascellaro, A; Vezzoli, P; Virgili, A; Zanca, A | Articolo su rivista | |
| 1-gen-2018 | Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients | Galluzzo, M; D’Adamio, S; Pastorino, R; Angela Andreoli, A; Servoli, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2021 | Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study | Patruno, C; Fabbrocini, G; Longo, G; Argenziano, G; Ferrucci, Sm; Stingeni, L; Peris, K; Ortoncelli, M; Offidani, A; Amoruso, Gf; Talamonti, M; Girolomoni, G; Grieco, T; Iannone, M; Nettis, E; Foti, C; Rongioletti, F; Corazza, M; Veneri, Md; Napolitano, M; Angileri, L; Bianchelli, T; Borghi, A; Calabrese, G; Chello, C; Dal Bello, G; Dastoli, S; Ferrillo, M; Galluzzo, M; Gori, N; Hansel, K; Macchia, L; Piras, V; Provenzano, E; Ribero, S; Romanelli, M; Romita, P | Articolo su rivista | |
| 1-gen-2018 | Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study | Chimenti, Ms; Ortolan, A; Lorenzin, M; Triggianese, P; Talamonti, M; Costa, L; Caso, F; Favero, M; Teoli, M; Galluzzo, M; Scarpa, R; Punzi, L; Perricone, R; Ramonda, R | Articolo su rivista | |
| 1-gen-2011 | Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis | Talamonti, M; Galluzzo, M; Teoli, M; Bavetta, M; Chimenti, S; Costanzo, A | Intervento a convegno | |
| 1-gen-2019 | Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial | Puviani, M; Galluzzo, M; Talamonti, M; Mazzilli, S; Campione, E; Bianchi, L; Milani, M; Luppino, I; Micali, G | Articolo su rivista | |
| 7-mag-2022 | Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis | Galluzzo, M; Talamonti, M; Cioni, A; Maffei, V; Shumak, Rg; Tofani, L; Bianchi, L; Campione, E | Articolo su rivista | |
| 1-gen-2019 | Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study | Chimenti, Ms; Fonti, Gl; Conigliaro, P; Hitaj, J; Triggianese, P; Teoli, M; Galluzzo, M; Talamonti, M; Kroegler, B; Greco, E; Perricone, R | Articolo su rivista | |
| 1-mag-2013 | Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom | Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A | Intervento a convegno |